EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure

Mario Tranfa iD, Luigi Lorenzini, Lyduine E Collij, David Vállez García, Silvia Ingala, Giuseppe Pontillo, Leonard Pieperhoff, Alessio Maranzano iD, Robin Wolz, Sven Haller, Kaj Blennow, Giovanni Frisoni und 14 weitere

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Mario Tranfa und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Biomedical Sciences, University "Federico II", Naples, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Cerebral Small Vessel Diseases, White Matter, Diffusion Tensor Imaging. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EU/EFPIA Innovative Medicines Initiative (IMI), Horizon 2020, International Magnesium Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Alzheimer's disease (AD) and cerebral small vessel disease (cSVD), the two most common causes of dementia, are characterized by white matter (WM) alterations diverging from the physiological changes occurring in healthy aging. Diffusion tensor imaging (DTI) is a valuable tool to quantify WM integrity non‐invasively and identify the determinants of such alterations. Here, we investigated main effects and interactions of AD pathology, APOE‐ε4, cSVD, and cardiovascular risk on spatial patterns of WM alterations in non‐demented older adults.

Methods

Within the prospective European Prevention of Alzheimer's Dementia study, we selected 606 participants (64.9 ± 7.2 years, 376 females) with baseline cerebrospinal fluid samples of amyloid β 1‐42 and p‐Tau 181 and MRI scans, including DTI scans. Longitudinal scans (mean follow‐up time = 1.3 ± 0.5 years) were obtained in a subset ( n = 223). WM integrity was assessed by extracting fractional anisotropy and mean diffusivity in relevant tracts. To identify the determinants of WM disruption, we performed a multimodel inference to identify the best linear mixed‐effects model for each tract.

Results

AD pathology, APOE‐ε4, cSVD burden, and cardiovascular risk were all associated with WM integrity within several tracts. While limbic tracts were mainly impacted by AD pathology and APOE‐ε4, commissural, associative, and projection tract integrity was more related to cSVD burden and cardiovascular risk. AD pathology and cSVD did not show any significant interaction effect.

Interpretation

Our results suggest that AD pathology and cSVD exert independent and spatially different effects on WM microstructure, supporting the role of DTI in disease monitoring and suggesting independent targets for preventive medicine approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCerebral Small Vessel DiseasesWhite MatterDiffusion Tensor ImagingHumansFemaleMaleAgedMiddle AgedAmyloid beta-PeptidesApolipoprotein E4tau ProteinsProspective Studies

Substanzen

Amyloid beta-PeptidesApolipoprotein E4tau Proteins

Autor:innen und Institutionen

  • Department of Advanced Biomedical Sciences, University "Federico II", Naples, Italy.
  • Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam, The Netherlands.
  • Amsterdam Neuroscience, Brain Imaging, Amsterdam, The Netherlands.
  • Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Department of Radiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Cerebriu A/S, Copenhagen, Denmark.

ORCID-Profile: Mario Tranfa, Alessio Maranzano, Gael Chételat, Michael Ewers, Pablo Martinez-Lage, Joanna M Wardlaw, Henk J M M Mutsaerts

Förderung

  • EU/EFPIA Innovative Medicines Initiative (IMI)
  • Horizon 2020
  • International Magnesium Institute
  • Horizon 2020 Framework Programme

Zitieren

APA

Tranfa, M., Lorenzini, L., Collij, L. E., Vállez García, D., Ingala, S., Pontillo, G., Pieperhoff, L., Maranzano, A., Wolz, R., Haller, S., Blennow, K., Frisoni, G., Sudre, C. H., Chételat, G., Ewers, M., Payoux, P., Waldman, A., Martinez-Lage, P., Schwarz, A. J., …, & Barkhof, F. (2024). Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52071

Vancouver

Tranfa M, Lorenzini L, Collij LE, Vállez García D, Ingala S, Pontillo G, et al. Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52071

BibTeX
@article{Tranfa2024,
  author = {Tranfa, Mario and Lorenzini, Luigi and Collij, Lyduine E and Vállez García, David and Ingala, Silvia and Pontillo, Giuseppe and Pieperhoff, Leonard and Maranzano, Alessio and Wolz, Robin and Haller, Sven and Blennow, Kaj and Frisoni, Giovanni and Sudre, Carole H and Chételat, Gael and Ewers, Michael and Payoux, Pierre and Waldman, Adam and Martinez-Lage, Pablo and Schwarz, Adam J and Ritchie, Craig W and Wardlaw, Joanna M and Gispert, Juan Domingo and Brunetti, Arturo and Mutsaerts, Henk J M M and Wink, Alle Meije and Barkhof, Frederik},
  title = {Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52071}
}
Kostenlos starten →